Références
-
de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez Protéomique dans la recherche translationnelle sur le cancer colorectal: la découverte de biomarqueurs pour des applications cliniques46:..
Clin Biochem 2013, 466-479
-
Lin L, J Piao, Gao W, Y Piao, Jin G, Ma Y, Li J, Lin Z: DEK sur l'expression comme un biomarqueur indépendant de mauvais pronostic dans le cancer colorectalBioMed.
BMC Cancer 2013, 13:366
-
Abe M, Manola JB, Oh WK, Parslow DL, George DJ, Austin CL, Kantoff PW: Les concentrations plasmatiques de la protéine de choc thermique 70 chez les patients atteints de cancer de la prostate: un biomarqueur potentiel du cancer de la prostate3.
Cancer Clin prostate 2004, 49- 53.
-
Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N: identification basée sur la protéomique des auto-anticorps contre la protéine de choc thermique 70 comme marqueur diagnostique dans le carcinome spinocellulaire de l'œsophageLett.
Cancer 2008, 263:.280-290
< -
Ciocca DR, Calderwood SK: .les protéines de choc thermique dans le cancer: diagnostic, de pronostic, de prévision, et les implications de traitement
stress cellulaire Chaperons 2005, 10:.86-103
-
Calini V, Urani C, Camatini M: La surexpression de HSP70 est induite par les rayonnements ionisants dans C3H 10 T1 / 2 cellules et protège contre les dommages de l'ADN17:..
in vitro Toxicol 2003, 561-566
-
Rerole AL, Jego G, Garrido C: Hsp70: protéine anti-apoptotique et tumorigène787:..
Methods Mol Biol 2011, 205-230
-
Multhoff G: protéine de choc thermique 70 (Hsp70): localisation membrane, l'exportation et la pertinenceimmunologiques43:..
des méthodes 2007, 229-237
-
Lancaster GI, Febbraio MA: Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins.
J Biol Chem 2005, 280:23349-23355.
-
Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine.
-
Gross C, Hansch D, Gastpar R, Multhoff G: Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
Biol Chem 2003, 384:267-279.
-
Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, Multhoff G: The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.
J Immunol 2004, 172:972-980.
-
Bayer C, Liebhardt ME, Schmid TE, Trajkovic-Arsic M, Hube K, Specht HM, Schilling D, Gehrmann M, Stangl S, Siveke JT, Wilkens JJ, Multhoff G: Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models.
Int J Radiat Oncol Biol Phys 2014, 88:694-700.
-
Kleinjung T, Arndt O, Feldmann HJ, Bockmühl U, Gehrmann M, Zilch T, Pfister K, Schönberger J, Marienhagen J, Eilles C, Rossbacher L, Multhoff G: Heat shock protein 70 (Hsp70) membrane expression on head-and-neck cancer biopsy-a target for natural killer (NK) cells.
Int J Radiat Oncol Biol Phys 2003, 57:820-826.
-
Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G:Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial.
Clin Cancer Res 2004, 10:3699-3707.
-
Dutta SK, Girotra M, Singla M, Dutta A, Otis Stephen F, Nair PP, Merchant NB: Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
Pancreas 2012, 41:530-534.
-
Dakappagari N, Neely L, Tangri S, Lundgren K, Hipolito L, Estrellado A, Burrows F, Zhang H:An investigation into the potential use of serum Hsp70 as a novel tumor biomarker for Hsp90 inhibitors.
Biomarkers 2010, 15:31-38.
-
Baumann M, Liertz C, Baisch H, Wiegel T, Lorenzen J, Arps H: Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice.
-
Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A: Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer.
Radiother Oncol 2010, 95:350-358.
-
De Maio A: Heat shock proteins: facts, thoughts, and dreams.
Shock 1999, 11:1-12.
-
Gross C, Schmidt-Wolf IG, Nagaraj S, Gastpar R, Ellwart J, Kunz-Schughart LA, Multhoff G:Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.
Cell Stress Chaperones 2003, 8:348-360.
-
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection.
-
Kocsis J, Madaras B, Toth EK, Fust G, Prohaszka Z: Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis.
-
Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, Hoetzenecker K, Rozsas A, Ostoros G, Laszlo V, Hofbauer H, Renyi-Vamos F, Klepetko W, Dome B, Ankersmit HJ:Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case–control study.
Clin Chim Acta 2012, 413:1115-1120.